首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備 DDS

市場調查報告書

商品編碼

2051141

緩釋藥物遞送市場：依技術、治療領域、應用及地區分類

Controlled Release Drug Delivery Market, By Technology, By Therapeutic Area, By Application, By Geography

出版日期: 2026年03月30日 | 出版商:

Coherent Market Insights | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年，緩釋藥物遞送市場規模估計為646億美元，預計到2033年將達到1,340.8億美元。預計從2026年到2033年，該市場將以11.0%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	646億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	11.00%	2033 年預計值：	1340.8億美元

緩釋給藥機制能夠將藥物的活性成分或藥物在數小時至數天內持續釋放。與傳統給藥方式相比，緩釋給藥具有許多優勢，包括減少給藥頻率、提高療效和降低副作用。慢性病盛行率的上升、老年人口的成長、大型企業研發投入的增加、技術的進步等因素，都可能推動市場成長。然而，緩釋產品的高成本以及嚴格的監管核准流程，可能會為參與企業帶來挑戰。

市場動態

全球緩釋藥物市場成長的主要驅動力是糖尿病、癌症和心血管疾病等慢性病盛行率的上升。根據世界衛生組織統計，2021年慢性病導致的死亡人數佔全球整體死亡總數的70%以上。緩釋藥物能夠長期維持體內藥物濃度的穩定，有助於更好地控制慢性病。老年人口的不斷成長，尤其是老年人更容易患慢性病，也可能促進市場成長。然而，緩釋藥物研發的高成本和漫長的臨床試驗週期可能會阻礙市場成長。緩釋藥物遞送機制的技術進步、消費者對長效藥物日益成長的需求，以及針對罕見病特藥研發的重點，都可能為市場相關人員帶來新的成長機會。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數創建了全球緩釋藥物輸送市場主要公司的概況：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球緩釋藥物輸送市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球緩釋藥物輸送市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

公司簡介
- Orbis Biosciences, Inc.
- Merck and Co., Inc.
- Alkermes plc
- Johnson and Johnson
- Coating Place, Inc.
- Corium International, Inc.
- Depomed, Inc.
- Pfizer, Inc
- Aradigm Corporation
- Capsugel.
- Abbott Laboratories
- Roche Holdings AG
- AstraZeneca
- Baxter International Inc
- Teva Pharmaceutical Industries Ltd.
- Bristol-Myers Squibb Company

第10章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI7133

Controlled Release Drug Delivery Market is estimated to be valued at USD 64.60 Bn in 2026 and is expected to reach USD 134.08 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 64.60 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.00%	2033 Value Projection:	USD 134.08 Bn

Controlled release delivery mechanism helps in delivering a pharmaceutical active compound or drug over an extended period of time, from hours to days. It offers several advantages over conventional drug delivery such as reduced dosing frequency, better therapeutic effectiveness and lower side effects. Factors such as growing prevalence of chronic diseases, rising geriatric population, increasing R&D investments by major players and technological advancements can drive the market growth. However, high costs associated with developing controlled release products and stringent regulatory approval process can pose challenges for the market players.

Market Dynamics

Global controlled release drug delivery market growth is driven by rising prevalence of chronic diseases such as diabetes, cancer and cardiovascular diseases. According to the WHO, chronic diseases accounted for over 70% deaths worldwide in 2021. Controlled release drugs help in better management of chronic conditions through constant drug levels in the body over an extended time period. Growing geriatric population prone to chronic illnesses can also drive the market growth. However, high costs associated with developing controlled release formulations and long duration of clinical trials can hamper the market growth. Technological advancements in controlled release drug delivery mechanisms, growing preference for long-acting pharmaceuticals, and focus on developing specialty drugs for orphan diseases can offer growth opportunities for market players.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global controlled release drug delivery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Depomed, Coating Place, Corium, and Johnson and Johnson
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global controlled release drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global controlled release drug delivery market.

Market Segmentation

Technology Insights (Revenue, USD Bn, 2021 - 2033)
Wurster Technique
Coacervation
Micro Encapsulation
Transdermal
Targeted Delivery
Others
Therapeutic Area Insights (Revenue, USD Bn, 2021 - 2033)
Infectious Diseases
Oncology
Cardiology
Neurology
Autoimmune Diseases
Others
Application Insights (Revenue, USD Bn, 2021 - 2033)
Metered Dose Inhalers
Injectables
Infusion Pumps
Drug Eluting Stents
Others
Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Orbis Biosciences, Inc.
Merck and Co., Inc.
Alkermes plc
Johnson and Johnson
Coating Place, Inc.
Corium International, Inc.
Depomed, Inc.
Pfizer, Inc
Aradigm Corporation
Capsugel
Abbott Laboratories
Roche Holdings AG
AstraZeneca
Baxter International Inc
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb Company

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Controlled Release Drug Delivery Market, By Technology, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Wurster Technique
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Coacervation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Micro Encapsulation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Transdermal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Targeted Delivery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Controlled Release Drug Delivery Market, By Therapeutic Area, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Autoimmune Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Controlled Release Drug Delivery Market, By Application, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Metered Dose Inhalers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Injectables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Infusion Pumps
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Drug Eluting Stents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Controlled Release Drug Delivery Market, By Distribution Channel, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Retail Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Online Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Controlled Release Drug Delivery Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Orbis Biosciences, Inc.
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck and Co., Inc.
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Alkermes plc
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Johnson and Johnson
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Coating Place, Inc.
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Corium International, Inc.
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Depomed, Inc.
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer, Inc
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Aradigm Corporation
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Capsugel.
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Abbott Laboratories
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Roche Holdings AG
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AstraZeneca
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Baxter International Inc
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bristol-Myers Squibb Company
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies